Showing results (11-20 of 27) with videos related to
Sort By:
Pageof 3
Parasites & Vectors|January 17, 2014
Distribution and dissemination of the Val1016Ile and Phe1534Cys Kdr mutations in Aedes aegypti Brazilian natural populationsJutta Gerlinde Birggitt Linss, Luiz Paulo Brito, Gabriela Azambuja Garcia, et al.Nature|March 10, 2016
Co-ordinated ocular development from human iPS cells and recovery of corneal functionRyuhei Hayashi, Yuki Ishikawa, Yuzuru Sasamoto, et al.Clinical Genitourinary Cancer|September 21, 2025
Impact of Impaired Renal Function on the Efficacy and Safety of Enfortumab Vedotin Monotherapy in a Multicenter Real-World Cohort of Patients With Metastatic Urothelial Cancer: YUSHIMA StudyHiroshi Fukushima, Yuki Nakamura, Hajime Tanaka, et al.International Journal of Urology : Official Journal of the Japanese Urological Association|November 24, 2018
Incidence and predictive factors of hypoglycemia after pheochromocytoma resectionSaori Araki, Toshiki Kijima, Yuma Waseda, et al.International Journal of Urology : Official Journal of the Japanese Urological Association|July 16, 2024
Outcomes and prognostic factors in patients with synchronous and metachronous oligometastatic urothelial carcinoma with visceral metastasesSoichiro Yoshida, Yuya Maezawa, Kensaku Ishihara, et al.International Journal of Urology : Official Journal of the Japanese Urological Association|April 11, 2026
Prognostic Significance of Hypoalbuminemia in Maintenance Avelumab Therapy After First-Line Chemotherapy for Metastatic Urothelial Carcinoma: A Multicenter Real-World Study (YUSHIMA Study)Rie Muta, Hiroshi Fukushima, Hajime Tanaka, et al.Clinical Genitourinary Cancer|January 28, 2025
Enfortumab Vedotin for Metastatic Urothelial Carcinoma: Comprehensive Treatment Outcomes and Prognostic Insights From a Multicenter Real-World Study (YUSHIMA Study)Yuki Nakamura, Hajime Tanaka, Noboru Numao, et al.International Journal of Clinical Oncology|April 21, 2025
Prognostic factors and effect of existing predictive models in oligo-metastatic urothelial carcinoma (YUSHIMA study)Kenji Tanabe, Soichiro Yoshida, Tomoki Kimura, et al.International Journal of Clinical Oncology|June 4, 2024
Gustave Roussy Immune score as a prognostic biomarker in patients with platinum-refractory metastatic urothelial carcinoma treated with pembrolizumab: YUSHIMA studyKenji Tanabe, Shuichiro Kobayashi, Yuya Maezawa, et al.International Journal of Urology : Official Journal of the Japanese Urological Association|June 4, 2025
Real-World Outcomes of First-Line Systematic Treatment in Locally Advanced or Metastatic Upper Urinary Tract Urothelial Carcinoma With Renal Impairment (YUSHIMA Study)Tomoki Kimura, Motohiro Fujiwara, Yuya Maezawa, et al.Pageof 3